Key result
Cardiomyocyte BH4 deletion improves LV recovery and reduces infarct size after ex vivo ischaemia-reperfusion injury.
Why the study?
The physiological roles of cardiomyocyte-derived tetrahydrobiopterin (BH4) in cardiac metabolism and stress response were unknown.
Does targeted deletion of cardiomyocyte BH4 synthesis reduce ischaemia-reperfusion injury in a mouse model?
Does targeted deletion of cardiomyocyte BH4 synthesis reduce ischaemia-reperfusion injury in a mouse model?
Reduction of cardiomyocyte BH4 confers a protective effect against cardiac ischaemia-reperfusion injury by shifting metabolism from fatty acids to glucose.
Preclinical cardioprotection from cardiomyocyte BH4 deletion requires human validation; leaves open metabolic targeting as a research avenue.
NEW FINDINGS: What is the central question of this study? What are the physiological roles of cardiomyocyte-derived tetrahydrobiopterin (BH4) in cardiac metabolism and stress response? What is the main finding and its importance? Cardiomyocyte BH4 has a physiological role in cardiac metabolism. There was a shift of substrate preference from fatty acid to glucose in hearts with targeted deletion of BH4 synthesis. The changes in fatty-acid metabolic profile were associated with a protective effect in response to ischaemia-reperfusion (IR) injury, and reduced infarct size. Manipulating fatty acid metabolism via BH4 availability could play a therapeutic role in limiting IR injury. ABSTRACT: (WT) littermates. Transcriptomic analyses and protein assays revealed downregulation of genes involved in fatty acid oxidation in cmGch1 KO hearts compared with WT, accompanied by increased triacylglycerol concentration within the myocardium. Deletion of cardiomyocyte BH4 did not alter basal cardiac function. However, the recovery of left ventricle function was improved in cmGch1 KO hearts when subjected to ex vivo ischaemia-reperfusion (IR) injury, with reduced infarct size compared to WT hearts. Metabolomic analyses of cardiac tissue after IR revealed that long-chain fatty acids were increased in cmGch1 KO hearts compared to WT, whereas at 5 min reperfusion (post-35 min ischaemia) fatty acid metabolite levels were higher in WT compared to cmGch1 KO hearts. These results indicate a new role for BH4 in cardiomyocyte fatty acid metabolism, such that reduction of cardiomyocyte BH4 confers a protective effect in response to cardiac IR injury. Manipulating cardiac metabolism via BH4 could play a therapeutic role in limiting IR injury.
No takes yet. Share an insight, caveat, or question.
Chu et al. (2023) studied Ischaemia-reperfusion injury. Targeted deletion of cardiomyocyte BH4 synthesis (cmGch1 KO) vs. Wild-type (WT) littermates was evaluated on Recovery of left ventricle function and infarct size after ex vivo ischaemia-reperfusion injury. Targeted deletion of cardiomyocyte BH4 synthesis improved recovery of left ventricle function and reduced infarct size following ex vivo ischaemia-reperfusion injury compared to wild-type hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: